Medyria
PrivateLast Round
VC Round
Jul 16, 2025
Total Funding Raised
$10.34M
Company Overview
Medyria is a medtech company that has developed sensor-based medical devices designed to measure blood flow velocity.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medyria Comps
Public and private peers based on sector, stage, and business model.
Medyria Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 16, 2025 | ||||
| Series C | Jan 11, 2023 | ||||
| Series B | Feb 12, 2018 | ||||
| Series A | Jan 29, 2015 |
Key People
Founding team and executive leadership
Medyria Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Series A, Series B |
| EFI Lake Geneva Ventures | Series C |
| Buenavista Equity Partners | VC Round |
| Zurcher Kantonalbank | Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2025
$1.87M raised in a VC round.
- Mar 1, 2025
Pilot clinical study launched for PyCath product with Clinical Accelerator.
Medyria Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medyria's valuation, stock price, and market status.
